Semaglutide Peptide Product Specifications:

The Semaglutide peptide, a synthetic peptide, mimics the structure of glucagon-like peptide-1 (GLP-1). Scientists engineer it with 31 amino acids, incorporating a C18 fatty diacid. Consequently, this modification enhances its stability. Moreover, its design resists enzymatic breakdown. Thus, it fascinates researchers in peptide science.

The Semaglutide peptide binds strongly to GLP-1 receptors, showing high affinity. Furthermore, it maintains structural integrity in the body. As a result, scientists study its molecular interactions. Additionally, its production uses advanced synthesis techniques. Hence, researchers explore its manufacturing process.

The Semaglutide peptide’s development by Novo Nordisk marks a scientific milestone. Initially, researchers crafted it in the 2000s for experimental studies. Subsequently, its name reflects its GLP-1-based structure. Moreover, it garners attention in global laboratories. Therefore, it fuels innovative biochemical research.

In studies, the semaglutide peptide circulates effectively in biological systems. Furthermore, it exhibits a prolonged half-life of about one week. Consequently, scientists investigate its pharmacokinetic traits. Additionally, labs worldwide analyze its chemical properties.

• Appearance:White powder
• Chemical Formula:C187H291N45O59
• PubChem CID:56843331
• CAS Number:910463-68-2
• Molecular Weight:4113.64 g/mol
• Storage:Not provided
• Synonyms:Oxempic, Rybelsus, NN9535
• Concentration:≥98%